Every day, I see more BPC-157, TB-500, and other longevity / recovery peptides being promoted online with claims like: Heal fast
The human PK data gap As of 2026, no completed Phase 1 pharmacokinetic, Phase 2 efficacy, or Phase 3 confirmation trials of BPC-157 have been published in the peer-reviewed clinical trial literature
Besides the FSP1-CoQ pathway, recent evidence has revealed an alternative ferroptosis defense mechanism involving dihydroorotate dehydrogenase (DHODH) and coenzyme Q10
Low glutathione levels are found in people with lupus, rheumatoid arthritis (RA), Crohns disease (IBD), multiple sclerosis (MS), and psoriasis.[ref] Related articles: Lupus, Rheumatoid arthritis, IBD, MS, and psoriasis genes Cystic fibrosis: People with cystic fibrosis, which is a genetic disease caused by mutations in the CFTR gene, have frequent respiratory infections that cause lung inflammation and produce oxidative stress in the lungs, which depletes glutathione levels
Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample
